- Home
- KRYS vs GATX Comparison
KRYS vs GATX Comparison
Compare KRYS & GATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRYS
- GATX
- Stock Information
- Founded
- KRYS 2015
- GATX 1898
- Country
- KRYS United States
- GATX United States
- Employees
- KRYS N/A
- GATX N/A
- Industry
- KRYS Biotechnology: Biological Products (No Diagnostic Substances)
- GATX Transportation Services
- Sector
- KRYS Health Care
- GATX Consumer Discretionary
- Exchange
- KRYS Nasdaq
- GATX Nasdaq
- Market Cap
- KRYS 4.7B
- GATX 5.5B
- IPO Year
- KRYS 2017
- GATX N/A
- Fundamental
- Price
- KRYS $196.65
- GATX $155.40
- Analyst Decision
- KRYS Strong Buy
- GATX Strong Buy
- Analyst Count
- KRYS 9
- GATX 3
- Target Price
- KRYS $214.22
- GATX $192.67
- AVG Volume (30 Days)
- KRYS 316.5K
- GATX 195.0K
- Earning Date
- KRYS 11-03-2025
- GATX 10-21-2025
- Dividend Yield
- KRYS N/A
- GATX 1.57%
- EPS Growth
- KRYS 275.72
- GATX 14.17
- EPS
- KRYS 6.66
- GATX 8.56
- Revenue
- KRYS $373,164,000.00
- GATX $1,704,900,000.00
- Revenue This Year
- KRYS $34.33
- GATX $11.64
- Revenue Next Year
- KRYS $48.04
- GATX $5.48
- P/E Ratio
- KRYS $29.71
- GATX $18.12
- Revenue Growth
- KRYS 54.51
- GATX 10.66
- 52 Week Low
- KRYS $122.80
- GATX $139.44
- 52 Week High
- KRYS $212.98
- GATX $178.26
- Technical
- Relative Strength Index (RSI)
- KRYS 59.19
- GATX 34.16
- Support Level
- KRYS $194.92
- GATX $150.42
- Resistance Level
- KRYS $212.98
- GATX $162.84
- Average True Range (ATR)
- KRYS 8.35
- GATX 4.66
- MACD
- KRYS -0.17
- GATX -0.92
- Stochastic Oscillator
- KRYS 42.14
- GATX 22.08
About KRYS Krystal Biotech Inc.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.
About GATX GATX Corporation
GATX Corp is a provider of railcar leasing and maintenance services. GATX operates in business segments including rail North America, rail international, Engine Leasing, and others. The rail business offers railcar leasing and maintenance, as well as asset-related, financial, and management services. The company owns and leases fleets in North America, Europe, and Asia, which consist of tank and freight railcars. Industries served include refining and petroleum, chemicals and plastics, railroads and other transportation, mining, and food and agriculture.